Literature DB >> 9787106

Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD).

J Lee1, X Jiao, J F Hejtmancik, M Kaiser-Kupfer, G J Chader.   

Abstract

Bietti crystalline dystrophy (BCD) is an autosomal recessive retinal degeneration characterized by intraretinal lipid inclusions with degeneration of the retina and sclerosis of the choroidal vessels, resulting clinically in progressive night blindness and constriction of the visual fields. Characterization of fatty acid metabolism in Bietti crystalline dystrophy suggested that BCD might result from abnormalities in lipid-binding proteins or one or more enzymes active in fatty acid elongation and desaturation. To further investigate the first possibility, the docosahexaenoic acid-binding proteins (DHABPs) of human lymphocytes from patients with Bietti crystalline dystrophy were studied and compared with those of normal controls. For fatty acid-binding protein (FABP) identification, lymphocyte cytosol was first subjected to Lipidex 1000 chromatography. FABPs were then cross-linked with [14C]22:6n-3 and identified by HPLC and SDS-PAGE. Ten major peaks corresponding to calculated molecular weights of 13, 14, 32, 43, 45, 50, 64, 96, 105, and 186 kDa exhibit high-affinity binding of fatty acids. Significantly, peaks corresponding to two fatty acid-binding proteins of 32 and 45 kDa present in age-matched controls are absent from lymphocytes of patients with BCD. The 32-kDa fatty acid-binding protein present in normal individuals but absent from patients with BCD was isolated from cultured control human lymphocytes, its fatty acid-binding properties were characterized, and its amino acid composition was analyzed. It shows specific binding of 3n-3 fatty acids, consistent with the pattern of abnormalities of lipid metabolism demonstrated in patients with BCD. These results suggest that the 32- and 43-kDa FABPs are reasonable candidates for causing BCD. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787106     DOI: 10.1006/mgme.1998.2723

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Generation and characterization of a murine model of Bietti crystalline dystrophy.

Authors:  Catherine M Lockhart; Mariko Nakano; Allan E Rettie; Edward J Kelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-12       Impact factor: 4.799

2.  Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35.

Authors:  X Jiao; F L Munier; F Iwata; M Hayakawa; A Kanai; J Lee; D F Schorderet; M S Chen; M Kaiser-Kupfer; J F Hejtmancik
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

3.  Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy.

Authors:  Xiaodong Jiao; Anren Li; Zi-Bing Jin; Xinjing Wang; Alessandro Iannaccone; Elias I Traboulsi; Michael B Gorin; Francesca Simonelli; J Fielding Hejtmancik
Journal:  Eur J Hum Genet       Date:  2017-01-04       Impact factor: 4.246

4.  Novel CYP4V2 mutations associated with Bietti crystalline corneoretinal dystrophy in Chinese patients.

Authors:  Rong Tian; Shu-Ran Wang; Jing Wang; You-Xin Chen
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  Human secretory immune response to fatty acid-binding protein fraction from Giardia lamblia.

Authors:  S M T Hasan; M Maachee; O M Córdova; R Diaz de la Guardia; M Martins; A Osuna
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Evolution of Cellular Inclusions in Bietti's Crystalline Dystrophy.

Authors:  Emiko Furusato; J Douglas Cameron; Chi-Chao Chan
Journal:  Ophthalmol Eye Dis       Date:  2010-03-09

7.  A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.

Authors:  Yanping Song; Guoyan Mo; Guohua Yin
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

8.  Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.

Authors:  Anren Li; Xiaodong Jiao; Francis L Munier; Daniel F Schorderet; Wenliang Yao; Fumino Iwata; Mutsuko Hayakawa; Atsushi Kanai; Muh Shy Chen; Richard Alan Lewis; John Heckenlively; Richard G Weleber; Elias I Traboulsi; Qingjiong Zhang; Xueshan Xiao; Muriel Kaiser-Kupfer; Yuri V Sergeev; J Fielding Hejtmancik
Journal:  Am J Hum Genet       Date:  2004-03-23       Impact factor: 11.025

9.  Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa.

Authors:  Yun Wang; Liheng Guo; Su-Ping Cai; Meizhi Dai; Qiaona Yang; Wenhan Yu; Naihong Yan; Xiaomin Zhou; Jin Fu; Xinwu Guo; Pengfei Han; Jun Wang; Xuyang Liu
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  A case of Bietti crystalline dystrophy with preserved visual acuity and extinguished electroretinogram: a case report.

Authors:  Ali Tabatabaei; Mohammad Soleimani; Sasan Moghimi; Mohammad Yaser Kiarudi
Journal:  Cases J       Date:  2009-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.